Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
April 30th, 2019
10.6K views
The direct rapid immunohistochemical test (DRIT) offers a World Organization for Animal Health and World Health Organization (OIE/WHO) recognized alternative to the direct fluorescent antibody (DFA) test for rabies diagnosis. This test allows for field-based applications that can be performed in approximately 1 h upon brain impressions using light microscopy.
Overview
The direct rapid immunohistochemical test (DRIT) is a recognized alternative for rabies diagnosis, allowing for field-based applications. This test can be performed in approximately one hour using light microscopy, making it accessible for decentralized laboratories.
Key Study Components
Area of Science
- Immunohistochemistry
- Rabies Diagnosis
- Field Applications
Background
- The DRIT is an alternative to the direct fluorescent antibody (DFA) test.
- It is suitable for use in areas lacking access to advanced microscopy.
- The test is designed for rapid results in rabies surveillance.
- It can be utilized by both laboratorians and field biologists.
Purpose of Study
- To provide a rapid and economical tool for rabies diagnosis.
- To enhance rabies surveillance, prevention, and control programs globally.
- To facilitate the diagnosis in decentralized settings.
Methods Used
- Sample collection from the brainstem of animals.
- Preparation of staining solutions and slides.
- Immunohistochemical staining using anti-rabies virus antibodies.
- Microscopic examination of the slides for viral inclusions.
Main Results
- Positive results show red intracytoplasmic viral inclusions in CNS tissue.
- Inclusions vary in shape and size, indicating rabies infection.
- Antigen distribution is graded, providing a measure of infection severity.
- Results can be obtained within one hour, enhancing diagnostic efficiency.
Conclusions
- The DRIT is a valuable tool for rapid rabies diagnosis.
- It supports improved rabies control efforts in various settings.
- Field-based applications can significantly enhance surveillance capabilities.
Frequently Asked Questions
What is the DRIT?
The DRIT is a rapid immunohistochemical test for diagnosing rabies.
How long does the DRIT take?
The test can be completed in approximately one hour.
What are the advantages of using the DRIT?
It allows for field-based applications and does not require advanced microscopy.
Who can use the DRIT?
Laboratorians and field biologists can utilize this test.
What does a positive result indicate?
A positive result shows red intracytoplasmic viral inclusions in CNS tissue.
How is the sample prepared for the DRIT?
Samples are collected from the brainstem and prepared for staining.
What is the significance of the DRIT?
It provides a rapid and economical tool for rabies diagnosis, enhancing surveillance efforts.
Executive Industry Relevance
Rabies surveillance requires rapid, field-deployable diagnostic tools to support timely public health decisions in resource-limited settings. The Direct Rapid Immunohistochemical Test (DRIT) enables decentralized testing with light microscopy, reducing reliance on specialized infrastructure. This approach strengthens surveillance continuity and supports go/no-go decisions in zoonotic disease management programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of rabies virus antigen presence in neural tissue to validate therapeutic targets.
- Operational Value: Provides standardized tissue preparation and staining protocols for reproducible target engagement assessment.
Screening & Assay Development
- Scientific Value: Generates quantitative antigen distribution scoring (plus one to plus four) for assay sensitivity and specificity benchmarking.
- Operational Value: Supports high-throughput sample processing with >94,000 wildlife tests demonstrating scalability for surveillance programs.
Translational & Preclinical Research
- Scientific Value: Facilitates disease-relevant model validation by confirming rabies infection status in preclinical studies.
- Operational Value: Enables cross-functional collaboration between lab and field teams through standardized, visually interpretable results.
Pipeline & Workflow Integration
The DRIT fits within early discovery workflows where rapid target validation informs lead identification and preclinical progression decisions.
- Discovery Biology: Supports hypothesis testing by detecting viral inclusions in CNS tissue to confirm mechanism of action.
- Screening: Delivers assay readiness through standardized touch impression preparation and one-hour turnaround time.
- Analytics: Provides graded antigen distribution output enabling comparative analysis across experimental conditions.
- Translational Research: Connects discovery findings to preclinical validation via consistent rabies detection in animal models.
- Enterprise Reuse: Functions as a reusable diagnostic platform applicable across species and geographic surveillance zones.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through direct visualization of rabies virus antigens.
- Operational Value: Standardization and reproducibility via formalin fixation and biotin-streptavidin peroxidase detection.
- Strategic Value: Improved go/no-go decisions by reducing false negatives in surveillance data.
- Portfolio Impact: Risk-adjusted prioritization of intervention strategies based on confirmed epizootic activity.
Implementation Considerations
- Requires expertise in histological techniques and biosafety level 2 practices for neural tissue handling.
- Dependent on light microscopy, antibody conjugates, and chromogen substrates for visual detection.
- Necessitates standardization of touch impression thickness and staining timing across users.
- Adaptation considerations include species-specific brain tissue accessibility and field storage conditions.
- Practical limitations include dependency on sample freshness and potential interference from autolytic changes.
Biopharma FAQs
Why does antigen distribution scoring matter for target validation?
Antigen distribution scoring from plus one to plus four provides a quantitative measure of rabies virus presence in CNS tissue, enabling researchers to assess target engagement levels and infection severity in preclinical models.
How does touch impression preparation support independent variable isolation in discovery workflows?
Touch impression preparation transfers only one or two layers of cells to the slide, minimizing tissue thickness and background interference to isolate the variable of viral antigen expression in neural tissue.
What quantitative dependent variable measurements does the DRIT enable for assay development?
The DRIT enables measurement of antigen distribution grading and inclusion intensity as dependent variables, which correlate with viral load and support assay sensitivity and specificity evaluations.
Why do replication requirements matter for cross-functional collaboration in surveillance programs?
Replication requirements ensure consistent results across users and locations, which is critical for aligning laboratory and field teams on surveillance data interpretation and public health decision-making.
What statistical analysis capabilities are required before implementing the DRIT in surveillance workflows?
Implementation requires capability to analyze graded antigen distribution data, including frequency of positive fields and inclusion intensity, to determine statistical significance of surveillance findings across sample populations.
